aap reduces growth expectation for fiscal 2008

Management Board Changes at aap Implantate AG: Biense Visser New CEO

aap reports Nine-Month Sales of EUR 24.2 million (+30%) and EBIT of EUR 1.3 million (+16%)

aap: 30% Nine-Month Sales Growth to EUR 24.2 million

aap signs distribution agreement for EASYMIX®

aap closed 5% Capital Increase successfully

aap Implantate AG plans 5% Capital Increase

aap reports first-half sales of EUR 16.3 million (+28%) and EBIT of EUR 1.7 million (+113%)

New date for the annual shareholders meeting

aap reports first-half year organic increase in sales of 29%

aap: Separation of Trauma & Orthopaedics no longer pursued

CE-approval for new orthopaedic bone cement Hi-Fatigue® G with antibiotics

aap Posts € 8.0 Million (+36%) in Sales and an EBIT of € 0.7 Million in First Quarter of 2008

aap Annual Financial Statements for 2007: Sales +52%, EBIT +36%

Medtronic launches aap´s NANOSTIM®

aap 2007: Strong sales growth to EUR 28.1 million (+52%) due to fourth quarter’s sales record